DexCom Inc (DXCM)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account

Sell

$66.95

Buy

$68.83

arrow-down$-1.98 (-2.87%)

Prices updated at 13 Dec 2025, 00:33 EST

Prices minimum 15 mins delay

Prices in USD

DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Devices

Chairman

Mr. Mark G. Foletta

CEO

Mr. Kevin R. Sayer, C.P.A.

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

10,300

Head office

6340 Sequence Drive

San Diego

United States

92121

+1 858 200-0200

investorrelations@dexcom.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Kevin R. Sayer, C.P.A. President, Chief Executive Officer and Chairman of the Board	1.16m
Mr. Mark G. Foletta Lead Independent Director and Interim Chairman Of The Board	-
Ms. Renee D. Gala Independent Director	-
Mr. Jacob S. Leach Interim Principal Executive Officer, President and Chief Operating Officer	0.68m
Dr. Euan Ashley Independent Director	-
Mr. Steven R. Altman Independent Director	-
Mr. Nicholas Augustinos Independent Director	-
Ms. Bridgette P. Heller Independent Director	-
Mr. Jereme M. Sylvain Executive Vice President, Chief Financial Officer and Principal Accounting Officer	0.61m
Mr. Richard A. Collins Independent Director	-
Mr. Kyle Malady Independent Director	-
Ms. Sadie M. Stern Executive Vice President and Chief Human Resources Officer	0.54m
Mr. Michael J. Brown Executive Vice President and Chief Legal Officer	0.60m
Ms. Rimma Driscoll Independent Director	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Tudor Investment Corp Et AL	69,150,000
Vanguard Group Inc	48,322,405
BlackRock Inc	38,821,843
State Street Corp	16,855,113
BlackRock Fund Advisors	16,107,305

Director dealings

Date chevron-l-regular chevron-r-regular	Action
16 Dec 2024	-
16 Dec 2024	-
16 Dec 2024	-
16 Dec 2024	-
20 Nov 2024	-
15 Nov 2024	-
16 Sep 2024	-
09 Sep 2024	-
09 Sep 2024	-
09 Sep 2024	-
30 Aug 2024	-
31 Jul 2024	-
28 Jun 2024	-
17 Jun 2024	-
18 Jun 2024	-
18 Jun 2024	-
17 Jun 2024	-
17 Jun 2024	-
14 Jun 2024	-
10 Jun 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.